Steve B. Warnecke

Insider Reports History

Entity
Individual
Location
C/O Targeted Medical Pharma, Inc., 2980 Beverly Glen Circle, Suite 301, Los Angeles, CA
Signature
/s/ Steve B. Warnecke
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steve B. Warnecke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EVOLUTIONARY GENOMICS, INC. Chairman, CEO, Director, 10%+ Owner Common Stock 1.84M $1.29M $0.70 May 23, 2022 Direct
EVOLUTIONARY GENOMICS, INC. Chairman, CEO, Director, 10%+ Owner Stock Option (right to buy) 0 May 23, 2022 Direct

Insider Reports Filed by Steve B. Warnecke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FNAM EVOLUTIONARY GENOMICS, INC. May 23, 2022 3 $0.15 4 May 25, 2022 Chairman, CEO, Director, 10%+ Owner
FNAM EVOLUTIONARY GENOMICS, INC. Mar 25, 2022 1 $0 4 Mar 31, 2022 Chairman/CEO, Director, 10%+ Owner
FNAM EVOLUTIONARY GENOMICS, INC. May 19, 2021 2 $0 4 May 21, 2021 Chairman/CEO, Director, 10%+ Owner